TJ Biopharma

About TJ Biopharma

Tianjing Bio is a full‑chain biopharmaceutical company focused on autoimmune diseases, tumor immunology, and metabolic diseases. Leveraging an integrated value chain with a Hangzhou GMP production base and Shanghai/Beijing R&D centers, it pursues drug discovery, clinical development, GMP manufacturing, and commercialization partnerships to deliver innovative biologics globally. The company emphasizes a differentiated two‑tier pipeline and an AntibodyPLUS platform to advance first‑in‑class therapies across stages from preclinical to late‑clinical development. Based in China with a global footprint, Tianjing Bio aims to create sustainable revenue through a mix of licensed products, CDMO manufacturing, and commercialization collaborations.